Work

Current Progress in Therapeutic Gene Editing for Monogenic Diseases

Year: 2016
Type: review
Abstract: Programmable nucleases allow defined alterations in the genome with ease-of-use, efficiency, and specificity. Their availability has led to accurate and widespread genome engineering, with multiple applications in basic research, biotechnology, and therapy. With regard to human gene therapy, nuclease-based gene editing has facilitated development of a broad range of therapeutic strategies based on both nonhomologous end joining and homology-dependent repair. This review discusses current progress in nuclease-based therapeutic applications for a subset of inherited monogenic diseases including cystic fibrosis, Duchenne muscular dystrophy, diseases of the bone marrow, and hemophilia and highlights associated challenges and future prospects.
Authors: Versha Prakash, Marc Moore, Rafael J Yáñez-Muñoz
Language: English
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W2325985500
FWCI: 1.377
Cites: 122
Cited by: 150
Related to: 10